Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs MiniMed Group Inc. Common Stock (MMED) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Halozyme Therapeutics Inc. Common Stock vs MiniMed Group Inc. Common Stock — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $111.34 (market cap $12.58B), while MiniMed Group Inc. Common Stock trades at $19.69 (market cap $5.57B). The key difference: Halozyme Therapeutics Inc. Common Stock is far larger — about 2.3× MiniMed Group Inc. Common Stock's market cap, and Halozyme Therapeutics Inc. Common Stock is trading nearer its 52-week high, MiniMed Group Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and MiniMed Group Inc. Common Stock for 1 Days on average.
| HALO | MMED | |
|---|---|---|
Market Cap | $12.58B | $5.57B |
Volume | 2,179,278 | 23,336,073 |
Sector | Health | Health |
52-Week High | $115.22 | $23.84 |
52-Week Low | $61.63 | $10.80 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $14.49B | $5.37B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →About MiniMed Group Inc. Common Stock
MiniMed develops, manufactures, and markets diabetes-management technologies. Its products include insulin-delivery systems, continuous glucose monitors, smart insulin pens, and related software.
Read more on MMED →
